Cardiovascular complications of polychemotherapy of oncohematological diseases: Modern approaches to diagnostics
Heart dysfunction that occurred after using of cytostatic drugs and monoclonal antibodies may be a limit factor in treatment of oncohematological diseases. Side effects of chemotherapy include decline of quality of life, hypotension, hypertension, arrhythmias, conduction disturbances, pericarditis,...
Main Author: | B. B. Samura |
---|---|
Format: | Article |
Language: | English |
Published: |
Zaporozhye State Medical University
2012-12-01
|
Series: | Zaporožskij Medicinskij Žurnal |
Subjects: | |
Online Access: | http://zmj.zsmu.edu.ua/article/view/18015/15762 |
Similar Items
-
Chronic lymphoproliferative diseases and cardiovascular risk (a literature review)
by: B. B. Samura, et al.
Published: (2022-11-01) -
Cardiovascular events after polychemotherapy of multiple myeloma: modern ways to diagnostics
by: B. B. Samura, et al.
Published: (2020-03-01) -
Cardiovascular events after polychemotherapy of oncohematological diseases: modern ways to prevention and treatment
by: B. B. Samura
Published: (2013-06-01) -
A case of irreversible cardiomyopathy induced by polychemotherapy
by: I S Skopets, et al.
Published: (2015-12-01) -
Exploiting Nanomedicine for Cancer Polychemotherapy: Recent Advances and Clinical Applications
by: Elena Boggio, et al.
Published: (2023-03-01)